K223738

Substantially Equivalent

Alpha Control Liner System (ACLS)

Applicant: Coapt
Product code: GXY
Advisory panel: Neurology
Date received: 2022-12-14
Decision date: 2023-01-11
Decision: Substantially Equivalent
Clearance type: Special
Location: Chicago, IL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.